Kursprognose für Kailera Therapeutics Inc (KLRA)KLRAKailera Therapeutics Inc

Alphio's KLRA stock price prediction model matches the current Kailera Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.88 (+0.22%). The 1-week path is $12.71 (-1.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kailera Therapeutics is a good buy right now due to its promising pipeline and strong analyst support. The current price is $11.25, significantly below the lowest analyst target of $30, indicating a potential upside of 167%. Additionally, the company has a current ratio of 11.11, suggesting strong liquidity, which is crucial for funding its clinical trials. However, the primary risk is its negative earnings per share (EPS) of -1.09, indicating ongoing losses that need to be addressed for long-term viability.

Kailera Therapeutics Inc (KLRA) last closed at $12.85, losing -3.17%. These facts feed the 1-day and 1-week KLRA price prediction above.